Recent Updates
Recently added Catalysts
ARWR Neutral Sentiment Score: 50/100

Arrowhead Pharmaceuticals to Host a Webinar on its Cardiometabolic Pipeline as Part I of the 2026 Summer Series of R&D Webinars

Key Takeaway: Arrowhead Pharmaceuticals is set to host a webinar focusing on its cardiometabolic pipeline. This event is part of the 2026 Summer Series of R&D webinars. Details regarding the specific topics or speakers were not provided in the announcement.

Market Sentiment Analysis

Full Press Release Details

Powered and protected by Privacy
Last updated: Jun 18, 2026